Form 4 for VCYT VERACYTE, INC.
Accepted 2022-11-15 00:00:00 ET · period of report 2022-11-11 · accession 0001384101-22-000145 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-15 | 2022-11-11 | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | M - OptEx | $14.34 | +2 | 68.0K | +0.0% | +$28.68 |
| D | 2022-11-15 | 2022-11-11 | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | S - Sale+OE | $29.34 | -2 | 68.0K | -0.0% | -$58.68 |
| D | 2022-11-15 | 2022-11-11 | VCYT | Kennedy Giulia C | Chief Scientific, Med Off | M - OptEx | $0.00 | -2 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-11 | M | A | 2 | $14.34 | 68,003 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-11 | S | D | 2 | $29.34 | 68,001 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2022-11-11 | M | D | 2 | $0.00 | 0 | D | $14.34 · — to 2024-02-18 | 2 Common Stock | (F2) The option is fully vested. |